Credit Available - See Credits tab below.
The Endocrine Society designates this live activity for a maximum of 4.25 ABIM MOC Points. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
|Accreditation Statement (0.19 MB)||Available after Purchase|
Jennifer A. Sipos, MD, Program Co-Chair, is a Professor of Medicine and Director of the Benign Thyroid Disorders Program at The Ohio State University. She obtained her medical degree and received her Internal Medicine residency training at Wake Forest University. She completed her Endocrinology and Metabolism fellowship at the University of North Carolina in Chapel Hill. Dr. Sipos has developed an interest in the use of ultrasonography for the diagnosis and management of thyroid cancer and has taught and served as a course director for numerous ultrasound courses nationally and internationally, including meetings for the Endocrine Society, American Thyroid Association, European Thyroid Association, American Association for Clinical Endocrinologists, Asia and Oceania Thyroid Association, Indian Endocrine Society, and International Society of Endocrinology. Additionally, she is actively involved in several clinical research projects with a particular interest in factors implicated in the development of salivary damage after radioiodine therapy. She also participates in clinical trials for the evaluation of multikinase inhibitor therapies in refractory thyroid cancer and the diagnostic use of molecular markers in thyroid nodules.
Ralph P. Tufano, MD, MBA, FACS, Program Co-Chair, is the Charles W. Cummings MD Endowed Professor in the Department of Otolaryngology-Head and Neck Surgery at the Johns Hopkins University School of Medicine. Dr. Tufano serves as the department’s Director of the Division of Head and Neck Endocrine Surgery and the American Head and Neck Society accredited fellowship in Endocrine Surgery. He serves on the Board of the American Thyroid Association and the Endocrine Section of the American Head and Neck Society. He was also instrumental in the establishment of the Surgical Affairs Committee for the ATA and served as its inaugural co-chair. He is also the recent past chair of the American Academy of Otolaryngology’s Endocrine Surgery Committee. He has authored over 175 peer-reviewed papers, and more than 30 textbook chapters related to thyroid and parathyroid diseases which have helped to define surgical management in this area. His research interests include novel directed therapies for the treatment of thyroid and parathyroid diseases, prognostic molecular markers for differentiated thyroid cancer, clinical outcomes research especially for transoral thyroid and parathyroid surgery, and determining the value propositions of thyroid and parathyroid surgical care episodes.
Peter Angelos, MD, PhD, FACS is the Linda Kohler Anderson Professor of Surgery and Surgical Ethics, Chief of Endocrine Surgery, and Associate Director of the MacLean Center for Clinical Medical Ethics at the University of Chicago Medicine. He completed his undergraduate degree, medical school, and a Ph.D. in Philosophy at Boston University. He completed his residency in General Surgery at Northwestern University and went on to complete fellowships in Clinical Ethics at the University of Chicago and in Endocrine Surgery at the University of Michigan. Dr. Angelos has written widely on improving outcomes of thyroid and parathyroid surgery, minimally invasive endocrine surgery, and ethical aspects in the care of surgical patients.
Yoshimi Anzai, MD, MPH is Professor of Radiology at the University of Utah. Dr. Anzai currently serves as Associate Chief Medical Quality Officer of the University of Utah Health Care. Dr. Anzai completed her Diagnostic Radiology residency and neuroradiology fellowship training at the University of Michigan. In 2000, she moved to the University of Washington, Seattle where she had served as the neuroradiology fellowship director from 2004-2008 and subsequently served as the section chief from 2008-2015. Dr. Anzai has been a longstanding member of many academic organizations, including ASNR, ASHNR, RSNA, AUR, ACR, and AAWR. She has over 17 years of experience in working as a neuroradiologist in leading academic institutions with a background of health services research. Her area of imaging research interest includes head and neck cancer imaging, traumatic brain injury, and neurodegenerative disease. She is also involved in the cost effectiveness and comparative effectiveness of diagnostic tests in various conditions. She also leads the implementation of imaging clinical decision support system to facilitate appropriate use of diagnostic imaging tests at the University of Utah.
Maria E. Cabanillas, MD is an Oncologic Endocrinologist at the University of Texas MD Anderson Cancer Center in Houston, Texas. She is a tenured Associate Professor and the Faculty Director of Clinical Research in the department of Endocrine Neoplasia at MD Anderson. As a clinician and clinical researcher she treats both early and advanced thyroid cancers, including medullary, differentiated, and anaplastic thyroid cancers. Her research focus is in advanced and aggressive thyroid cancer, with an emphasis that includes molecular targeted therapies and immunotherapy. Dr. Cabanillas serves as the principal investigator on several clinical trials for the treatment of advanced thyroid cancer and is an IRB vice-chair. She has been a member of the International Thyroid Oncology Group (ITOG) since 2012 and is currently on the Board of Directors.
M. Regina Castro, MD is an Associate Professor of Medicine at Mayo Clinic Medical School. She is a consultant in the Division of Endocrinology at Mayo Clinic, where she is currently Associate Program Director of the Endocrinology Fellowship Program and the Director of Internal Medicine Residency Rotation in Endocrinology. She served as a member of the ATA Board of Directors from 2014-2018 and as Chair of the Patient Education and Affairs committee since 2015 to present. She is a member of the Mayo Clinic Thyroid Core group. Her clinical and research interests are in the treatment of patients with thyroid disease, particularly thyroid nodules and thyroid cancer, areas in which she has published extensively.
Andrew G. Gianoukakis, MD is a Professor of Medicine in the Geffen School of Medicine at UCLA. Dr. Gianoukakis is a clinician educator and clinical researcher. He serves as program director of the Harbor-UCLA Endocrinology and Metabolism training program and has served on the Association of Program Directors in Endocrinology and Metabolism (APDEM) council since 2015. Dr. Gianoukakis heads the thyroid unit at Harbor-UCLA Medical Center and directs the Thyroid Nodule Aspiration and Thyroid Oncology clinics. He directs a research team performing phase II-III clinical thyroid cancer trials and studies. He is a member of the International Thyroid Oncology Group (ITOG) serving as a member of the Board as well as chair of ITOG’s Membership Committee. Additionally, Dr. Gianoukakis serves as secretary of the Southern California Thyroid Cancer Consortium (SCThyCC), and advisory board member of the National Graves’ Disease and Thyroid Foundation (GDATF) and the Thyroid Cancer Survivors Association (ThyCa).
Melanie Goldfarb, MD, MS, FACS, FACE is an Associate Professor of Surgery and the Director of the Center for Endocrine Tumors and Disorders at the John Wayne Cancer Institute and Providence Saint Johns Health Center. She is a fellowship-trained endocrine surgeon that is an expert in minimally invasive thyroid, parathyroid, and adrenal surgery. She also serves as the Medical Director for Cancer Survivorship. After graduating from Brown University and the University of Illinois College of Medicine, she completed her general surgery residency at Harvard Medical School an endocrine surgery fellowship at the University of Miami, and a Masters in clinical and translational research at the University of Southern California. She. She serves as the co-chair of the American Thyroid Association research committee and is on the editorial board of Thyroid. She has authored more than 65 peer-reviewed papers and 45 published abstracts. Her research interests include health disparities and clinical outcomes of endocrine tumors, young adult cancer, cancer survivorship, secondary malignancies, and quality of life for thyroid cancer patients.
Megan R. Haymart, MD is an Associate Professor of Medicine at the University of Michigan with a primary appointment in the Division of Metabolism, Endocrinology, and Diabetes and a secondary appointment in the Division of Hematology/Oncology. Dr. Haymart's research focuses on variation in the management of thyroid cancer with an emphasis on the role of patients, providers, and health systems in thyroid cancer diagnosis and treatment. She also studies thyroid cancer outcomes and the rise in thyroid cancer incidence. She is Principal Investigator of the NCI-funded R01 grant “Treatment Decision Making in Low-Risk Thyroid Cancer” and the AHRQ-funded R01 grant “Imaging Practices and Overdiagnosis of Thyroid Cancer”. Dr. Haymart received her medical degree from Johns Hopkins University School of Medicine in 2002, completed internal medicine residency at Johns Hopkins Hospital in 2005, and then completed fellowship in endocrinology, diabetes and metabolism at the University of Wisconsin in 2007. In 2009, she joined the University of Michigan faculty as Assistant Professor of Medicine and in 2017 she was promoted to Associate Professor of Medicine. Dr. Haymart is involved in creating the National Comprehensive Cancer Network thyroid carcinoma guidelines, is on the Board of Directors for the American Thyroid Association, serves on the editorial board for the Journal of Clinical Oncology, and is Associate Editor for Thyroid.
Allen S. Ho, MD is a board-certified, fellowship-trained head and neck surgeon. His practice focuses on the treatment of head and neck tumors, including HPV(+) throat cancers and thyroid malignancies. As Director of the Head and Neck Cancer Program and Co-Director of the Thyroid Cancer Program, he leads the multidisciplinary Cedars-Sinai Head and Neck Tumor Board. Dr. Ho’s research interests are highly integrated into his clinical practice. His current efforts lie in cancer proteomics, HPV(+) oropharyngeal cancer pathogenesis, and thyroid cancer molecular assays. Dr. Ho has published as lead author in journals that include Nature Genetics, JCO, JAMA Oncology, and Thyroid, and is Co-Editor of the textbook Multidisciplinary Care of the Head and Neck Cancer Patient (Springer 2018). Dr. Ho serves on national committees within the AHNS and ATA, and leads a national trial on thyroid cancer active surveillance (ClinicalTrials.gov ID: NCT02609685). He maintains expertise in transoral robotic surgery (TORS), minimally invasive thyroidectomy approaches, and nerve preservation techniques. Dr. Ho’s overarching aim is to partner with patients to optimize treatment and provide compassionate, exceptional care.
Emad Kandil, MD, MBA, FACS, FACE is a Professor of Surgery, the Elias Hanna Endowed Chair in Surgery and the Chief of General, Endocrine and Oncological Surgery Division at Tulane University Medical School, New Orleans, LA. He is also a senior executive member of Tulane cancer executive council and the director of the clinical Endocrine Surgery Fellowship at Tulane. He completed his training with a clinical fellowship in endocrine surgery at Johns Hopkins University School of Medicine. Dr. Kandil is a fellow of the prestigious American Surgical Association and a member of the Southern Surgical Association. He is also a fellow of American College of Surgeons and the American Association of Clinical Endocrinologists. He serves on several national and international committees, and served on multiple institutional leadership positions including being the Chair of General Medical Faculty. Dr. Kandil Is the presidnet of Surgical Association of Louisiana. Dr. Kandil has written over 300 original articles, invited reviews and book chapters and served on numerous editorial boards. Dr. Kandil has special interest in robotic endocrine surgery and he has the largest experience in US with robotic thyroid and parathyroid surgery using different approaches. He has lectured all over the world on topics related to endocrine surgery. Dr. Kandil received multiple national awards including the Shipley award by the Southern Surgical Association, in recognition of astute surgical scholarship. He is the founder of an annual national course on thyroid and parathyroid surgery – a program that is now in its 11th year. His research interests have focused on clinical outcome research related to endocrine surgery. His laboratory research focus is on identification of novel genetic markers for active surveillance and examining the anti-tumor efficacies of multiple pathways targeting thyroid cancer using in vitro and mouse-model cell in addition to human specimens.
Ana Ponce Kiess, MD, PhD is Assistant Professor and Residency Program Director in the Department of Radiation Oncology and Molecular Radiation Sciences at Johns Hopkins University. Her clinical and research focus is on the treatment of thyroid and head and neck cancers with external beam radiotherapy, as well as the treatment of multiple types of cancer with radiopharmaceutical therapies. She co-authored the AHNS consensus statement on EBRT for differentiated thyroid cancers.
Joshua P. Klopper, MD joined the Colorado Permanente Medical Group of Kaiser Permanente in July, 2015 and was appointed Chief of the department in April, 2016. He was appointed Associate Clinical Professor of Medicine in the Division of Endocrinology, Metabolism and Diabetes at the University of Colorado School of Medicine in October, 2015. He received his medical degree from the Emory University School of Medicine in Atlanta, Georgia in 1999 and completed his endocrinology fellowship at The University of Colorado School of Medicine in June 2006. Dr. Klopper was a full-time faculty member in the Division of Endocrinology at the University of Colorado School of Medicine from 2006-2015 where he specialized in the evaluation and management of thyroid nodules and thyroid cancer, including advanced thyroid cancer. He has served on the Clinical Affairs Committee and the Development Committee of the American Thyroid Association, the Endocrine Society Annual Meeting Steering Committee and has been the co-director of The Endocrine Society Introductory Hands-On Thyroid Ultrasound Workshop since 2014. He was elected to a 4-year term on the American Thyroid Association Board of Directors in 2018.
Jill E. Langer, MD is Ultrasound Section Chief and Professor of Radiology at the Perelman School of Medicine at the University of Pennsylvania with a secondary appointment in the Department of Medicine, Division of Endocrinology, Metabolism and Diabetes. She co-directs the Thyroid Nodule Clinic at the Hospital of the University of Pennsylvania with Dr. Susan Mandel.
Michael Carmi Singer, MD is the Director of the Division of Thyroid & Parathyroid Surgery at the Henry Ford Health System in Detroit, Michigan. Dr. Singer completed a fellowship in head and neck endocrine surgery at the Medical College of Georgia. A second fellowship in minimally invasive endocrine surgery augmented his experience with minimally invasive, endoscopic and robotic endocrine techniques. Dr. Singer’s practice is dedicated exclusively to the surgical management of thyroid and parathyroid diseases. He has published extensively on improving endocrine surgery outcomes and facilitating minimally invasive and robotic surgery. His research efforts are focused on surgical innovation and the development of surgical technology.
Elizabeth N. Pearce, MD is currently a Professor of Medicine at Boston University School of Medicine in the Section of Endocrinology, Diabetes, and Nutrition. She received her undergraduate and medical degrees from Harvard and a masters’ degree in epidemiology from the Boston University School of Public Health. She completed her residency in internal medicine at Beth Israel Deaconess Medical Center, and her fellowship in endocrinology at Boston University. Dr. Pearce is the 2018-2019 President of the American Thyroid Association. She also serves as the Regional Coordinator for North America for the Iodine Global Network. She is an Associate Editor at Thyroid and at Endocrine Practice and has served on multiple additional editorial boards, including those for the Journal of Clinical Endocrinology and Metabolism, Clinical Endocrinology, and Lancet Diabetes & Endocrinology. She recently co-chaired the American Thyroid Association’s Thyroid in Pregnancy Guidelines Task Force. Her research interests include the sufficiency of dietary iodine in the U.S., thyroid function in pregnancy, the thyroid effects of environmental perchlorate exposure, and the cardiovascular effects of subclinical thyroid dysfunction. Dr. Pearce was the 2011 recipient of the American Thyroid Association’s Van Meter Award for outstanding contributions to research on the thyroid gland and the 2018 Women in Thyroidology Woman of the Year.
Franklin Neil Tessler, MD is Professor Emeritus of Radiology and Senior Medical Officer for Health System Information Services at the University of Alabama at Birmingham, USA. He has 40 years of experience in ultrasound with a special interest in thyroid sonography. Dr. Tessler is a Fellow of the Society of Radiologists in Ultrasound (SRU) and the American Institute of Ultrasound in Medicine, and was a member of the panel that developed the SRU consensus guidelines for thyroid nodule management in 2004. He leads the committee that published the American College of Radiology TI-RADS in 2017 and heads the steering committee for the International Thyroid Nodule Ultrasound Working Group, which seeks to produce a unified system for thyroid nodule risk stratification and management with participants from multiple professional organizations around the globe. Dr. Tessler resides in Birmingham, Alabama with his wife, Debbie.
Mingbo Zhang, MD is an associate chief physician in the Department of Ultrasound, General Hospital of Chinese PLA. She has rich experience in ultrasound diagnosis of thyroid nodules, ultrasound-guided fine needle aspiration and core needle biopsy of thyroid nodules. In addition, she has completed different kinds of thyroid ablations, including radiofrequency ablation, laser ablation and microwave ablation. Her current research direction is clinical research on thyroid ablation therapy and AI assisted diagnosis of thyroid nodules. She has published 5 SCI articles and obtained many funds including the National Natural Science Foundation of China. She won the first prize in the ultrasound diagnosis competition of thyroid nodules over hundreds of ultrasound doctors and the artificial intelligence (AI). She was awarded as the best young ultrasound doctor in China.
Please wait ...